tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Abivax announces trading resumption of shares on Euronext Paris
PremiumThe FlyAbivax announces trading resumption of shares on Euronext Paris
1M ago
Abivax $400M Spot Secondary; price range $62.50-$65.00
Premium
The Fly
Abivax $400M Spot Secondary; price range $62.50-$65.00
2M ago
Abivax announces $400M ADS offering
Premium
The Fly
Abivax announces $400M ADS offering
2M ago
Abivax price target raised to $101 from $50 at Guggenheim
PremiumThe FlyAbivax price target raised to $101 from $50 at Guggenheim
2M ago
Abivax price target raised to $70 from $42 at Piper Sandler
Premium
The Fly
Abivax price target raised to $70 from $42 at Piper Sandler
2M ago
Promising Phase 3 Results and Broad Market Potential Drive Buy Rating for Obefazimod
Premium
Ratings
Promising Phase 3 Results and Broad Market Potential Drive Buy Rating for Obefazimod
2M ago
Citizens JMP healthcare analysts hold an analyst/industry conference call
PremiumThe FlyCitizens JMP healthcare analysts hold an analyst/industry conference call
2M ago
Abivax’s Obefazimod: A Promising Contender in Ulcerative Colitis Treatment with Potential Market Impact
Premium
Ratings
Abivax’s Obefazimod: A Promising Contender in Ulcerative Colitis Treatment with Potential Market Impact
2M ago
Positive Outlook for Abivax SA: Anticipated Success of Obefazimod in Ulcerative Colitis Treatment
Premium
Ratings
Positive Outlook for Abivax SA: Anticipated Success of Obefazimod in Ulcerative Colitis Treatment
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100